China's Fosun to sign agreement for $1.4 billion Gland Pharma buy: Economic Times

Shanghai Fosun Pharmaceutical (Group) Co (2196.HK) will sign a definitive agreement on Wednesday to buy a controlling stake in India's Gland Pharma in a $1.4 billion deal, the Economic Times newspaper reported, citing a source with direct knowledge.

DealsNorth AmericaUSBriefs